NASDAQ · Financial Statements
Adial Pharmaceuticals, Inc (ADIL) Financial Statements
$3.90
NASDAQ: ADIL
Market Cap $10.24M
Overview Financials Dividend Adial Pharmaceuticals, Inc most recently reported annual revenue of $0, net profit of $-8.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-19.0M $-11.0M $-7.0M $-8.0M $-8.0M Net Profit $-19.0M $-13.0M $-7.0M $-13.0M $-8.0M EPS $-653.00 $-299.50 $-136.00 $-17.75 $-11.93 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $8.0M $6.0M $5.0M $5.0M $7.0M Total Liabilities $4.0M $2.0M $1.0M $1.0M $2.0M Cash $6.0M $4.0M $3.0M $4.0M $6.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-12.0M $-11.0M $-7.0M $-7.0M $-6.0M Investing Cash Flow $0 $0 $8.0M $0 $0 Financing Cash Flow $2.0M $0 $0 $4.0M $0 Net Cash Flow $2.0M $-2.0M $-1.0M $1.0M $2.0M Free Cash Flow $-12.0M $-11.0M $0 $-7.0M $-6.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.01 EV / EBITDA 0.30 FCF Yield -97.46% Quick Ratio 5.63 Interest Coverage 0.00 Return 1Y -70.59% Return 3Y -98.45% Return 5Y -99.83%
Screens featuring this stock